Sponsored Links

Effects Of Intranodal Autologous Tumor Lysate-DC Vaccine With Aldesleukin (IL-2) And IFN-alpha2a In Metastatic Renal Cell Carcinoma Patients PDF Print E-mail
Medical News - Cancer Oncology
UroToday.com - Immunotherapy with interleukin 2 (IL-2) for metastatic renal cancer continues to offer a minority of patients the potential of durable complete responses without additional treatments...

Read more: Cancer / Oncology News From Medical News Today